No attachments available.
Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
Contact and place of performance
Michelle Cecilia
USA
This IDIQ includes both fixed-price and cost reimbursement opportunities at the task order level.
The National Institutes of Health, National Institute on Drug Abuse (NIDA) has awarded a contract for chemistry, manufacturing, and controls (CMC) and related services to support the development of drug products. This award facilitates the technical requirements necessary for advancing pharmaceutical candidates through various stages of the development lifecycle. Work performed under this requirement falls under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC AN12, Health R&D Services; Health Care Services; Applied Research.
The procurement was finalized as an Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which allows for the issuance of both fixed-price and cost-reimbursement task orders. Performance will take place within the United States. This award notice was published on August 12, 2024, under solicitation number 75N95023R00037, with Michelle Cecilia serving as the point of contact for the agency.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.